Tc-99m marked ciprofloxacin xanthate complex, as well as preparation method and application thereof

A technology of ciprofloxacin and xanthate, applied in the fields of radiopharmaceutical chemistry and clinical nuclear medicine, can solve the problems of low specificity, false positives and low labeling rate.

Active Publication Date: 2018-10-02
BEIJING NORMAL UNIVERSITY
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Technetium-99m labeled ciprofloxacin ( 99m Tc-ciprofloxacin) has been used clinically as a radiopharmaceutical for diagnosing inflammation. It can distinguish bacterial inflam

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Tc-99m marked ciprofloxacin xanthate complex, as well as preparation method and application thereof
  • Tc-99m marked ciprofloxacin xanthate complex, as well as preparation method and application thereof
  • Tc-99m marked ciprofloxacin xanthate complex, as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0043] Describe the present invention in detail below by embodiment: a kind of 99m TcN-CPF2XT complex, its structural formula is as follows:

[0044]

[0045] a. Synthesis of Ligand CPF2XT

[0046] Weigh 2.00g (6.00mmol) of ciprofloxacin, dissolve it in 100mL of anhydrous methanol, slowly add 1.72g (8.90mmol) p-toluenesulfonic acid, stir until the mixture is uniform and fully dissolved. Heated in an oil bath at 80°C, stirred and refluxed for 12 hours, and cooled to room temperature. Slowly add NaHCO 3 solution, with CH 2 Cl 2 Extraction (100mL×3), the organic phases were combined and dried over anhydrous magnesium sulfate, filtered, and rotary evaporated to obtain a white solid, compound I;

[0047] Weigh compound I1.00g (2.88mmol), K 2 CO 3 1.20g (8.64mmol) and bromoethanol 0.72g (5.76mmol), add 50mL of acetonitrile as solvent, heat in an oil bath at 80°C, stir and reflux for 12h; add appropriate amount of deionized water to the reaction system to dissolve, and use ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a <99m>TcN-CPF2XT complex, as well as a preparation method and application thereof. Ciprofloxacin containing a quinolone pharmacophoric group is converted into a ciprofloxacinxanthate ligand (CPF2XT) capable of being complexed with <99m>Tc, and a <99 m>TcN-CPF2XT complex is obtained by using a preparation process that an S atom in the CPF2XT ligand is complexed with [<99m>TcN]<2+> nuclear. The complex is a hydrotropic substance, and is high in radiochemical purity, good in stability, and simple and convenient to prepare; the complex is highly taken and retained at thebacterial inflammation part; the ratios of inflammation/muscle and inflammation/blood are high; bacterial inflammation can be distinguished from non-bacterial inflammation; and the complex can be used as a novel bacterial inflammation photographic developer to be popularized and applied.

Description

Technical field: [0001] The invention relates to the technical fields of radiopharmaceutical chemistry and clinical nuclear medicine, in particular to a technetium-99m labeled ciprofloxacin xanthate complex and its preparation method and application. Background technique: [0002] Inflammation is a common and important pathological process, and the inflammatory response is closely related to human health. Although the emergence of antibiotics has greatly improved the treatment of inflammation, with the development of modern medicine and the use of various chemotherapeutic agents, there are more and more patients with low immunity. In addition, the extensive use of antibiotics has also reduced the sensitivity of the body to these drugs. The global abuse of antibiotics has made bacteria more resistant to drugs, and even superbugs have emerged. Today, inflammation is still one of the most common diseases in human beings, especially in developing countries. How to effectively d...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07F13/00C07D215/56C07B59/00A61K51/04A61K103/10
CPCA61K51/0459C07B59/002C07B2200/05C07D215/56C07F13/005
Inventor 张俊波方思安张仕坚王学斌唐志刚陆洁
Owner BEIJING NORMAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products